Precipio Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Precipio Inc.
Precipio Inc is a healthcare solutions company focused on cancer diagnostics. It focuses on addressing the problem of cancer misdiagnoses by developing solutions to mitigate the root causes of this problem in the form of diagnostic products, reagents, and services. The company operates Clinical Laboratory Improvement Amendments laboratories in both the New Haven, Connecticut and Omaha, Nebraska locations providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. It provides new technologies to the oncology diagnostic laboratory market in the form of HemeScreen and IV-Cell product offerings. The company generates the majority of its revenue from third-party payers.
/ 
Frequently asked questions
To buy Precipio Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Precipio Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Precipio Inc. is PRPO:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Precipio Inc. has its primary listing on NASDAQ (Small cap). You can trade Precipio Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Precipio Inc. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Precipio Inc. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Precipio Inc..